Cai J J, Lee H C
Department of Internal Medicine, University of Iowa College of Medicine, Iowa City 52242, USA.
Mol Pharmacol. 1996 Jan;49(1):81-8.
We recently demonstrated that protein kinase C (PKC) activities were elevated in hypertrophic cardiomyopathic (HCM) hamster hearts and that activation of PKC resulted in stimulation of cAMP-dependent phosphodiesterase (PDE) activity. In this study, we determined the composition of PKC isozymes in control and HCM hearts and identified the PKC isozyme responsible for the modulation of PDE activity in HCM hearts. Using quantitative autoradiographic techniques with PKC isozyme-specific antibodies, we found that the PKC alpha, epsilon, and zeta isozymes were expressed in both control and HCM hearts. The immunoreactive amounts of cytosolic PKC alpha and PKC epsilon and of membrane PKC zeta were significantly increased in HCM hearts. The enzymatic activity of PKC in HCM hearts was significantly elevated in both membrane (148.0 +/- 13.7 versus 78.9 +/- 1.9 pmol/mg/min in controls, four experiments) and cytosol (117.3 +/- 5.1 versus 75.7 +/- 5.1 pmol/mg/min in controls, four experiments). Contribution of individual PKC isozyme activity was assessed by the immunoprecipitable PKC activity with isozyme-specific antibodies. The membrane PKC epsilon (41.7 +/- 4.9 versus 18.7 +/- 0.3 pmol/mg/min in controls, four experiments, p < 0.05) and PKC zeta (61.5 +/- 14.0 versus 20.3 +/- 2.7 pmol/mg/min in controls, four experiments, p < 0.05) but not PKC alpha (50.9 +/- 6.8 versus 44.3 +/- 1.5 pmol/mg/min, four experiments, p = N.S.) were increased in HCM hearts. On the other hand, the cytosolic PKC alpha (47.7 +/- 4.1 versus 27.0 +/- 1.4 pmol/mg/min, four experiments, p < 0.05) and PKC epsilon (42.8 +/- 3.1 versus 19.1 +/- 3.9 pmol/mg/min, four experiments, p < 0.05) but not PKC zeta (27.2 +/- 3.0 versus 32.0 +/- 2.1, four experiments, p = N.S.) were increased in HCM hearts. Furthermore, after immunoprecipitation of PKC alpha, activation of PKC could no longer potentiate the PDE activity in HCM hearts. Removal of PKC epsilon or PKC zeta, on the other hand, did not affect the PKC-mediated PDE stimulation in HCM hearts. These results suggest that there is an increase in the quantitative expression of PKC isozymes in HCM hearts and that the cross-talk between PKC and PDE in these hearts is mediated specifically via the PKC alpha isozyme.
我们最近证明,肥厚型心肌病(HCM)仓鼠心脏中的蛋白激酶C(PKC)活性升高,并且PKC的激活导致环磷酸腺苷(cAMP)依赖性磷酸二酯酶(PDE)活性增强。在本研究中,我们确定了对照心脏和HCM心脏中PKC同工酶的组成,并鉴定了负责调节HCM心脏中PDE活性的PKC同工酶。使用针对PKC同工酶特异性抗体的定量放射自显影技术,我们发现PKCα、ε和ζ同工酶在对照心脏和HCM心脏中均有表达。HCM心脏中胞质PKCα和PKCε以及膜PKCζ的免疫反应量显著增加。HCM心脏中PKC的酶活性在膜(四次实验,148.0±13.7对对照组的78.9±1.9 pmol/mg/min)和胞质(四次实验,117.3±5.1对对照组的75.7±5.1 pmol/mg/min)中均显著升高。通过用同工酶特异性抗体进行免疫沉淀的PKC活性评估单个PKC同工酶活性的贡献。HCM心脏中膜PKCε(四次实验,41.7±4.9对对照组的18.7±0.3 pmol/mg/min,p<0.05)和PKCζ(四次实验,61.5±14.0对对照组的20.3±2.7 pmol/mg/min,p<0.05)升高,但PKCα未升高(四次实验,50.9±6.8对44.3±1.5 pmol/mg/min,p=无显著性差异)。另一方面,HCM心脏中胞质PKCα(四次实验,47.7±4.1对27.0±1.4 pmol/mg/min,p<0.05)和PKCε(四次实验,42.8±3.1对19.1±3.9 pmol/mg/min,p<0.05)升高,但PKCζ未升高(四次实验,27.2±3.0对32.0±2.1,p=无显著性差异)。此外,PKCα免疫沉淀后,PKC的激活不再能增强HCM心脏中的PDE活性。另一方面,去除PKCε或PKCζ并不影响HCM心脏中PKC介导的PDE刺激。这些结果表明,HCM心脏中PKC同工酶的定量表达增加,并且这些心脏中PKC和PDE之间的相互作用是通过PKCα同工酶特异性介导的。